Built with thought-leaders at Sanofi, Eisai, AbbVie and Denali, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases.

With an emphasis on neurodegeneration, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges:

• Discover robust biomarkers of neuroinflammation to enable successful translation and patient stratification
• Navigate preclinical model limitations to better predict clinical efficacy
• Explore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches

Don’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic.

For more information, visit www.neuroimmunology-drugdevelopment.com